Potential Gene Therapy Targets for Auditory Damage! "Science" Decodes the Auditory Code

Potential Gene Therapy Targets for Auditory Damage! "Science" Decodes the Auditory Code

Recently, the journal Science published online a research paper titled "Casz1 is required for both inner hair cell fate stabilization and outer hair cell survival." This research was conducted by the team of Liu Zhiyong from the Chinese Academy of Sciences' Brain Science and Intelligence Technology Innovation Center (Neuroscience Research Institute). The study reports the dual role of the zinc finger transcription factor Casz1 in the fate stabilization and survival of auditory hair cells (hair cells, HC) and reveals the molecular mechanisms by which Casz1 exerts its function. This provides new insights and targets for exploring gene manipulation to repair auditory damage.

The auditory perception mechanism in mammals is rooted in two distinct types of hair cells within the cochlea: inner hair cells (IHC) and outer hair cells (OHC). These cells are topped with cilia, and when sound vibrations cause the cilia to deflect, they activate both IHCs and OHCs. In this sophisticated auditory system, OHCs function as sound amplifiers by enhancing sound signals through changes in their cell length, while IHCs serve as the primary sound receptors, forming synaptic connections with spiral ganglion neurons to transmit auditory information. However, approximately one-fifth of the global population suffers from varying degrees of hearing loss, with hair cell death caused by genetic mutations, noise pollution, and ototoxic drugs being one of the main causes of sensorineural deafness. Unfortunately, mammals, including humans, lose the ability to regenerate and repair hair cells once they are damaged. Therefore, understanding the molecular mechanisms of OHC and IHC fate determination and survival maintenance is crucial for developing treatments to restore hearing in deaf patients.

Recent research has revealed that Tbx2, as a key transcription factor, plays a central role in the fate determination, differentiation, and maintenance of IHCs, while Insm1 and Ikzf2 are critical for the fate maintenance, survival, and function of OHCs. Despite these findings, we still know little about the genetic regulatory network that precisely guides cochlear precursor cells to develop into OHCs and IHCs. In particular, it remains unclear whether there is a gene that can simultaneously regulate the fate stability and survival of both IHCs and OHCs. The research team led by Liu Zhiyong identified a conserved zinc finger transcription factor, Casz1, through comparative analysis of significantly differentially expressed genes in OHCs and IHCs. Casz1 is continuously expressed in IHCs from late embryonic stages to adulthood, while it is expressed transiently in OHCs during late embryonic and early postnatal stages.

Through systematic analysis of conditional Casz1 knockout mice, the research team found that in the absence of Casz1 during the embryonic stage, IHCs are still generated normally, but their fate becomes unstable. They begin to express OHC genes (such as Prestin) and progressively downregulate IHC genes (such as vGlut3), eventually completing a fate transformation from IHCs to OHCs, generating a type of OHC-like cells (induced OHC-like cells, iOHCs). Furthermore, the researchers found that conditional knockout of Casz1 after birth had little or no impact on IHC development, indicating that Casz1's core role is concentrated in the embryonic stage. It acts as a "guardian" to ensure the stability of IHC fate and prevent its transformation into OHCs. However, in OHCs, the role of Casz1 is entirely different, primarily focusing on maintaining OHC survival. Although OHCs deficient in Casz1 can complete early development, these cells inevitably begin to die as the mice reach adulthood. Due to the abnormalities in OHCs and IHCs, conditional Casz1 knockout mice eventually exhibit severe hearing impairment.

To gain a deeper understanding of how Casz1 regulates auditory hair cell (HC) development, the research team employed full-length single-cell transcriptome analysis to systematically analyze the changes in gene expression in OHCs and IHCs after Casz1 deletion. Subsequently, through genetic complementation experiments, they confirmed that the transcription factor Gata3 is a key downstream effector of Casz1, and its expression is significantly downregulated in IHCs lacking Casz1. Notably, complementing Gata3 in Casz1-deficient mice effectively suppresses the abnormal differentiation of IHCs and alleviates the death of OHCs, partially restoring the auditory function of the Casz1-deficient mice.

Given the importance of Tbx2 in IHC differentiation and Insm1's critical role in early OHC differentiation, the research team further utilized mouse genetics experiments to demonstrate that Tbx2 has an upstream regulatory effect on Casz1. Overexpression of Tbx2 can completely prevent the transdifferentiation of IHCs to OHCs in Casz1-deficient mice. Additionally, they found that the IHC-to-OHC transition mediated by Casz1 deletion does not depend on Insm1, indicating that this process does not follow the normal development pathway of OHCs.

In conclusion, the research team led by Liu Zhiyong, using techniques such as single-cell transcriptome analysis, electrophysiological recording, electron microscopy, cell function evaluation, and mouse genetic models, has for the first time revealed the dual function of Casz1 in auditory hair cells. Their research not only clarifies the role of the Tbx2-Casz1-Gata3 transcriptional regulatory pathway in the early fate stabilization of IHCs, but also highlights the necessity of Casz1 in cilia development and OHC survival (as shown in Figure 3). This breakthrough not only adds valuable information to the field of basic auditory science but also provides potential gene therapy targets to promote auditory hair cell regeneration and cilia function recovery, offering hope for patients with hearing loss and advancing the development of gene therapy for auditory hair cell damage.